Corporate Governance24 Sept 2026, 09:59 pm
Strides Pharma: Trading Window Closed for Q2 FY27 Results
AI Summary
Strides Pharma Science Ltd has announced the closure of its trading window for dealing in the company's shares. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ending September 30, 2026. The specific date for the Board Meeting to approve these results will be communicated separately. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for Q2 FY27 financial results.
- Window reopens 48 hours post-results declaration.
- Board meeting date for results to be announced later.
Price Impact
More from STAR